Go Pro

Virtus LifeSci Biotech Clinical Trials ETF (BBC) Chart & Stock Price History

$46.65 -3.19 (-6.40%)
Closing price 09/23/2026 04:10 PM Eastern
Extended Trading
$46.65 +0.00 (+0.00%)
As of 04:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Virtus LifeSci Biotech Clinical Trials ETF Stock Price Performance

The Virtus LifeSci Biotech Clinical Trials ETF (BBC) fund chart highlights key performance trends across multiple timeframes. Over the last 12 months, the fund's price has increased 78.87%, with a year-to-date return of 20.98%. In the past month, the fund has decreased 13.82%, reflecting recent market activity.

As of the latest close, Virtus LifeSci Biotech Clinical Trials ETF traded at $46.65 with a market cap of $44.32 million and volume of 34,243 shares. Five years ago, the fund traded at $47.59, representing a 1.98% decrease over that period. At the time, it had a market cap of $40.45 million and a volume of 1,633 shares.

Receive BBC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-4.03%
1 Month
Performance
-13.82%
3 Month
Performance
-5.11%
Year-To-Date
Performance
+20.98%
1 Year
Performance
+78.87%
5 Year
Performance
-1.98%

BBC Stock Chart for Thursday, September, 24, 2026

Virtus LifeSci Biotech Clinical Trials ETF Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
09/23/2026$49.84$46.65
-6.40%
$49.85$46.4534,243 shs$44.32 million
09/22/2026$48.69$49.84
+2.36%
$49.96$48.9312,068 shs$47.35 million
09/21/2026$48.61$48.69
+0.16%
$49.34$48.3817,633 shs$46.26 million
09/18/2026$49.25$48.61
-1.30%
$49.12$48.339,296 shs$2.92 million
09/17/2026$48.19$49.25
+2.20%
$50.15$49.027,248 shs$2.96 million
09/16/2026$48.54$48.19
-0.72%
$48.97$47.6514,661 shs$2.89 million
09/15/2026$49.94$48.54
-2.80%
$49.48$48.0619,422 shs$46.11 million
09/14/2026$49.38$49.94
+1.13%
$50.40$49.4310,447 shs$47.44 million
09/11/2026$49.91$49.38
-1.06%
$50.83$49.3042,750 shs$46.91 million
09/10/2026$51.51$49.91
-3.11%
$50.89$49.9113,244 shs$47.41 million
09/09/2026$53.17$51.51
-3.12%
$52.98$51.518,174 shs$48.93 million
09/08/2026$53.71$53.17
-1.01%
$53.73$52.448,597 shs$50.51 million
09/07/2026$53.71$53.71$53.76$53.006,795 shs$51.02 million
09/04/2026$53.39$53.71
+0.60%
$53.76$53.006,795 shs$51.02 million
09/03/2026$53.78$53.39
-0.73%
$53.91$53.009,858 shs$50.72 million
09/02/2026$52.91$53.78
+1.64%
$54.55$52.569,604 shs$51.09 million
09/01/2026$53.05$52.91
-0.26%
$52.94$52.228,240 shs$50.26 million
08/31/2026$53.29$53.05
-0.45%
$53.29$52.0632,465 shs$50.40 million
08/28/2026$55.34$53.29
-3.70%
$55.56$53.1818,256 shs$50.63 million
08/27/2026$55.15$55.34
+0.34%
$55.83$54.9220,412 shs$52.57 million
08/26/2026$55.76$55.15
-1.09%
$56.04$54.6737,342 shs$52.39 million
08/25/2026$54.13$55.76
+3.01%
$55.96$54.6627,918 shs$52.97 million
08/24/2026$54.46$54.13
-0.61%
$54.62$52.8116,211 shs$51.42 million

This page (NYSEARCA:BBC) was last updated on 9/23/2026 by MarketBeat.com Staff.
From Our Partners